Literature DB >> 7892827

Dose-response relations between urinary cadmium and tubular proteinuria in cadmium-exposed workers.

L Järup1, C G Elinder.   

Abstract

Cadmium in urine reflects the body burden in cadmium-exposed individuals. Urinary beta 2-microglobulin is frequently used as a marker of tubular proteinuria with an arbitrarily chosen value (34 micrograms/mmole creatinine) as the cut-off limit. Both this cut-off level and a lower limit (25 micrograms/mmole creatinine) were used in a study of the relationship between urinary cadmium and beta 2-microglobulin in 561 cadmium-exposed battery workers. There was a clear dose-response relation between the urinary cadmium level and the prevalence of tubular proteinuria ranging from 0.8% in the lowest exposure group, excreting less than 1 nmole cadmium/mmole creatinine, to 46.4% (50.0 for the lower cut-off level) in the highest exposure group with a mean urinary cadmium of 15 nmole/mmole creatinine. The relation between urinary cadmium and tubular proteinuria was also assessed using probit analysis. There was a 10% response at a urinary cadmium of 3 nmole/mmole creatinine. The impact of age on the dose-response relation was explored in two age groups with the cut-off point at 60 years of age, showing a 10% prevalence of tubular proteinuria at urinary cadmium levels of 1.5 nmole/mmole creatinine in this older age group and 5.0 nmole/mmole creatinine in the category under 60 years of age. The study thus indicates that the present health-based limit (10 nmole/mmole creatinine) proposed by the World Health Organization (WHO) is too high and it is suggested that a new limit should be set to 3 nmole/mmole creatinine.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7892827     DOI: 10.1002/ajim.4700260605

Source DB:  PubMed          Journal:  Am J Ind Med        ISSN: 0271-3586            Impact factor:   2.214


  7 in total

1.  Low level exposure to cadmium and early kidney damage: the OSCAR study.

Authors:  L Järup; L Hellström; T Alfvén; M D Carlsson; A Grubb; B Persson; C Pettersson; G Spång; A Schütz; C G Elinder
Journal:  Occup Environ Med       Date:  2000-10       Impact factor: 4.402

2.  In vivo analysis of cadmium in battery workers versus measurements of blood, urine, and workplace air.

Authors:  J Börjesson; T Bellander; L Järup; C G Elinder; S Mattsson
Journal:  Occup Environ Med       Date:  1997-06       Impact factor: 4.402

3.  Enzymuria in a population living near a cadmium battery plant.

Authors:  L Järup; M D Carlsson; C G Elinder; L Hellström; B Persson; A Schütz
Journal:  Occup Environ Med       Date:  1995-11       Impact factor: 4.402

4.  Decreased glomerular filtration rate in solderers exposed to cadmium.

Authors:  L Järup; B Persson; C G Elinder
Journal:  Occup Environ Med       Date:  1995-12       Impact factor: 4.402

5.  The threshold level of urinary cadmium associated with increased urinary excretion of retinol-binding protein and beta 2-microglobulin: a re-assessment in a large cohort of nickel-cadmium battery workers.

Authors:  Agnès Chaumont; Frédéric De Winter; Xavier Dumont; Vincent Haufroid; Alfred Bernard
Journal:  Occup Environ Med       Date:  2010-10-08       Impact factor: 4.402

Review 6.  Endemic Nephropathy Around the World.

Authors:  Fiona J Gifford; Robert M Gifford; Michael Eddleston; Neeraj Dhaun
Journal:  Kidney Int Rep       Date:  2017-03

7.  Cadmium and lead in blood in relation to low bone mineral density and tubular proteinuria.

Authors:  Tobias Alfvén; Lars Järup; Carl-Gustaf Elinder
Journal:  Environ Health Perspect       Date:  2002-07       Impact factor: 9.031

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.